BGPT: Paper Review: TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport

Explore by Goal

Quick Explanation Copied

TDP-43 forms a solid-like aggregate at ER exit sites (ERES) that traps secretory cargo

Using a mutant Hsp104-based aggregate reporter, the authors identify a TDP-43 “ERES aggregate” (TDP43-ERES) that is distinct from stress granules, recruits COPII components, becomes non-dynamic/solid-like, and correlates with ER→Golgi transport inhibition measured by RUSH assays—then they observe increased TDP43-ERES in ALS patient-derived motor neurons and ALS postmortem cortex.

Long Explanation

Paper Review (visual-first): TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport

Core claim: TDP-43 co-aggregates with SEC16A/COPII at mature ER exit sites to form a non-dynamic (solid-like) inclusion (TDP43-ERES) that retains ER→Golgi secretory reporters and delays ER-to-Golgi transport.

How they get there (high level): (i) broad labeling of stress-induced aggregates in human cells using mutant Hsp104 (DWB) that binds aggregates without disaggregation, (ii) affinity purification + LC–MS/MS to identify enriched proteins, (iii) imaging/biophysical assays to distinguish TDP43-ERES from stress granules, (iv) RUSH transport assays to test functional consequences, and (v) patient-relevance checks in ALS patient-derived motor neurons and ALS postmortem tissue.

Figure 1 — Aggregate proteomics scale & enrichment

The authors report 337 proteins enriched in Hsp104 DWB–bound aggregates (defined as >8.5-fold vs control), with top-enriched categories including stress/chaperone components and RNA metabolism/translation proteins.

Figure 2 — Solid-like vs dynamic behavior (FRAP mobile fraction)

The paper contrasts mobility/exchange of TDP43-ERES vs stress granules (SGs):

TDP43-ERES shows mobile fractions ~15% (TDP43) and ~10% (SEC16A) in partial FRAP, and <20% recovery after full photobleaching over ~2.5 minutes.
SGs show rapid mixing with mobile fractions >60% and much higher exchange with cytosol.

Figure 3 — “Cargo retention” criterion in the time-lapse RUSH analysis

The paper defines cargo retention using cross-correlation (CC) between the cargo reporter signal (RUSH-TNFα) and the SEC16A signal at ERES. They use a benchmark CC ≥ 0.5 to score retention.

Mechanistic pathway proposed by the authors (with skepticism)

Causal chain (as tested)

Proteotoxic stress induces TDP43 co-aggregation with SEC16A and COPII at ER exit sites, yielding TDP43-ERES.
TDP43-ERES recruit secretory cargo reporters (RUSH substrates) but fail to complete release/transport steps from ER to Golgi, causing ER export defects and delayed delivery.
Sufficiency test: artificially inducing TDP43/SEC16A co-aggregation at ERES (AP21967-driven FKBP/FRB* dimerization) reproduces cargo export failure, supporting that the aggregate localization/formation is sufficient to impair ER-to-Golgi transport.

Skeptical critique: what could still confound causality?

Overexpression & heterogeneity: Many mechanistic imaging results depend on transient/transgene expression levels and show cell-to-cell heterogeneity; while the authors acknowledge this and probe some aspects (e.g., SG modulation), heterogeneity can complicate interpretation of global trafficking impairment thresholds.
Reporter specificity: Mutant Hsp104 DWB is a heterologous aggregate-labeling tool. Even if it enriches misfolded/protein-inclusion contexts, it may not capture all physiologically relevant aggregate species, and it could also preferentially label certain conformations/assemblies. The authors use it as a reporter for aggregates broadly and validate with known aggregation-prone proteins, but the biological equivalence of “Hsp104-labeled” vs “all disease-relevant aggregates” remains an open question.
Stress paradigms vs disease chronicity: Key induction conditions include heat stress and proteasome inhibition (e.g., MG132) and artificial dimerization. These are strong perturbations and may not perfectly match chronic ALS-era cellular conditions; the study partially bridges this with ALS patient-derived iMNs and postmortem sections, but those are largely correlative for the specific causal mechanism in vivo.

Human relevance checks (what is reported, and what remains uncertain)

ALS patient-derived iMNs / iNeurons: The study reports increased volume percentage of TDP43-ERES (TDP43 co-aggregating with SEC16A) in motor neurons derived from ALS patient hiPSCs carrying c9orf72 mutations compared with non-ALS controls, with n reported as 90 cells in 3 normal vs 3 patient lines.
ALS postmortem motor cortex vs occipital cortex: In 11 ALS patients (sALS=10, fALS=1 as described), TDP43/SEC16A co-aggregation in motor cortex vs occipital cortex shows patient-specific fold changes (some ~3–4 fold; some >10) and morphologies described as consistent with diffuse punctate cytoplasmic staining-like patterns.

Uncertainty: The patient tissue evidence does not, by itself, prove that TDP43-ERES formation is the upstream cause of motor neuron degeneration; it establishes an association with ALS-relevant cellular pathology markers. The paper itself highlights the need for further investigation into causal relationships.

Visual logic map (author-proposed mechanism)

A compact directed representation of the paper’s experimental logic: reporter → proteomics → imaging/biophysics → transport assay → inducible sufficiency → patient relevance.

What would most strongly disprove this paper’s mechanistic core?

The paper argues: TDP43 aggregation at ERES causes ER-to-Golgi transport impairment. A decisive falsification would require showing that preventing TDP43 recruitment to ERES (or preventing aggregate maturation) restores cargo export under matched stress conditions, and that the induced sufficiency experiment fails when aggregate formation/localization is disrupted. The authors do perform an inducible co-aggregation sufficiency approach (AP21967 system), which strengthens the causal inference compared with purely correlational evidence.

Bottom line

The study provides a coherent, multi-assay mechanism linking TDP43 aggregation at mature ER exit sites to delayed ER-to-Golgi transport, supported by: (i) aggregate proteomics identifying ER-exit components in the Hsp104-labeled aggregate pool, (ii) imaging/biophysical evidence that the TDP43-containing ERES inclusions are non-dynamic, (iii) RUSH functional assays showing cargo retention and failure to release tubular intermediates, and (iv) an inducible co-aggregation sufficiency test.

Author reviews (open with BGPT)

Feedback:

Updated: May 01, 2026